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1. Introduction 
Chronic pancreatitis (CP) can be defined as an inflammatory disease with progressive and 
irreversible morphological changes (1). There is loss of endocrine and / or exocrine function, 
with or without pain (2-6). The structure is altered by inflammation, necrosis, fibrosis and 
loss of exocrine and endocrine elements (5,6). 
Alcoholism accounts for 70 to 80% of CP ; 10 to 20% are idiopathic and the remaining 5-10% 
are caused by hypercalcemia, trauma, hereditary diseases, hyperlipidemia (types I, IV and 
V) or nutritional causes (tropical pancreatitis) (3, 5, 6). 
CP is associated with a mortality rate of approximately 50% within 20 to 25 years after its 
onset (2,6). About 15 to 20% of patients die due to complications associated with attacks of 
CP, and most of the remaining deaths are due to trauma, malnutrition, infection or smoking 
(often associated with alcoholism) (2,6). Very little is known about the actual prevalence or 
incidence of CP, although estimates indicate an incidence of 3.5 to 4 cases per 100.000 (2,6). 
2. Symptomatology 
Clinical presentation of CP is characterized by attacks of pain (1). This is intense, localized in 
the epigastrium, radiating to the back and may also be present in the right or left 
hypochondria and be associated with nausea and vomiting (1). Usually lasts for hours, 
although some patients experience continuous pain for days or weeks (3, 5, 6). Along with 
the destruction of pancreatic tissue there are signs of endocrine pancreatic insufficiency 
(impaired glucose tolerance, diabetes mellitus) and / or exocrine (steatorrhea) (3, 5, 6). 
3. Diagnosis 
The diagnosis is based on morphological (abnormalities of pancreatic channels) and 
functional criteria (pancreatic insufficiency). Although it is easy in advanced forms (Figure 
1), in early stages, diagnosis is difficult (7). Ideal diagnostic criteria would be histological (8). 
However, pancreatic biopsy is susceptible to serious complications, especially in normal or 
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slightly impaired pancreas. In addition, irregular distribution of lesions can lead to 
diagnostic errors (false-negative) (8,9). 
  
(a) 
 
(b) 
Fig. 1. Image obtained by wirsungography (a): dilation of MPD and secondary branches. It 
suggests CP. Echoendoscopic image (b) of the same patient. Besides dilatation of main 
pancreatic duct (MPD), there are hyperechoic streaks, and hypoechoic areas permeating 
normal parenchyma. 
The development of a technique that could be able to detect early morphological 
abnormalities and besides that could search for specific cellular or CP biochemical markers 
in pancreatic juice would represent a significant advance in this field (6,9). 
4. Imaging  
Similar to AP, US is considered the first exam for patients with suspected CP (7). It shows 
localized or diffuse increase in pancreatic volume, irregularities and dilations of main 
pancreatic duct (MPD), or cystic collections adjacent to the gland, and pancreatic 
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calcifications (Figure 2) (2,9-11). Intravenous injection of secretin may be useful in early 
forms of CP, enhancing discrete changes in MPD caliber (12). Sensitivity and specificity of 
ultrasound to diagnose CP ranges from 50 to 70% and 80 to 90%, respectively (6, 10, 13). 
 
Fig. 2. Echoendoscopic image showing multiple hyperechoic areas with posterior acoustic 
shadow in a patient with calcifying CP. 
A study comparing US, CT and endoscopic retrograde cholangiopancreatography (ERCP) 
demonstrated that US has a sensitivity of 58% and specificity of 75% to diagnose CP (14). CT 
is more sensitive and accurate than plain films or US. The suggestive findings of CP include: 
glandular atrophy, irregularities in pancreatic contours, dilation and irregularities of 
pancreatic channels with pancreatic calcifications (15). CT is the most sensitive test to detect 
calcifications and it is still important to search for complications such as pseudocysts. CT 
sensitivity varies from 74 to 90% and its specificity is over 85% to diagnose CP (2,6). In 
aforementioned study, CT had a sensitivity of 75% and specificity of 95% (14). 
Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography 
(MRCP) are new non-invasive methods, (no sedation, no contrast, no endoscope insertion). 
They can obtain images of both parenchyma (MRI) and hepatic and billiary channels 
(MRCP). They can identify pancreatic atrophy, MPD stenosis or dilation, collateral branches 
dilation and intracanalicular lesions (16-18). 
Our experience is according to literature, and shows that the concordance between MRCP 
and ERCP varies from 83% to 92% in canalicular dilation, 70% to 92% in canalicular stenosis 
and 92% to 100% when intracanalicular lesions are present (16, 18, 19). Often, minor 
abnormalities detectable by ERCP are often undetectable by MRCP and, the rate of false-
positive results in canalicular stenosis is high (16,18). Although MRCP is useful to detect 
moderate and advanced forms of CP, it has a limited value in the early stages (9,18). 
Intravenous administration of secretin during MRCP is an alternative to enhance image of 
MPD in the early stages of CP, as it improves the diagnostic yield (20,21). Image 
interpretation should be cautious, keeping in mind that artifacts may occur during its 
reconstruction, leading to a misconception of obstruction, stenosis and stones (21, 22). 
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ERCP is considered the "gold standard" for diagnosis and treatment of CP (6, 9). Its 
sensitivity ranges from 74% to 95% and specificity from 90% to 100% (14). A recent study 
including 202 patients with suspected CP tried to compare the results of ERCP and 
pancreatic stimulation by secretin- pancreozymin test (TSP), as it is a more sensitive method 
to assess pancreatic function. The results showed significant correlation between ERCP and 
TSP, although in 21% of patients, they were discordant and in 15% the results have been 
contradictory (normal ERCP and abnormal TSP, or vice- versa) (23). 
ERCP has some limitations to diagnose CP. Failure in pancreatic channels opacification 
occurs in 7.5% of cases, particularly when there is an obstruction in the papillary region 
caused by a stone (9). Invasive nature of ERCP leads to a risk of acute pancreatitis in 5% to 
10% of cases, especially in normal or slightly altered pancreas (24). Pancreatography can be 
normal in 15% of CP and diagnosis is based on clinical course, pancreatic function tests or 
other imaging methods (6). This occurs more frequently in non-calcified forms of CP (2, 5, 6, 9). 
Recently, Tamura et al. (18) compared ERCP to MRI in patients with CP. The authors 
studied the results of both methods to measure the diameter and characteristics of MPD. 
The study showed that ERCP tends to overestimate MPD caliber and that MRI is more 
accurate to define discrete changes in its caliber (18) 
5. Echoendoscopy 
Echoendoscopy can evaluate in detail all the pancreatic parenchyma as well MPD with no 
fluoroscopy or contrast (25). Moreover, it is a less invasive method and so, unlike ERCP, the 
patient has no risk of acute pancreatitis. Echoendoscopic criteria for CP are based on 
parenchyma and canalicular abnormalities (Table 1) (26,27). 
 
Type of change  Catalano et al. Sahai et al. 
Parenchyma Parenchyma Ductal Parenchyma Ductal 
Echotexture Heterogeneous --- --- --- 
Focus Echogenic (1 to 
3 mm) 
--- Hyperechoic --- 
Streaks (interlobular septa) Hyperechoic --- Hyperechoic --- 
Lobulation Present --- Present --- 
Pancreatic duct     
Diameter --- > 3 mm --- Dilated 
Appearence --- Tortuous --- Irregular 
Hyperechoic focus 
inside 
--- Present --- --- 
Hyperechoic wall --- --- --- Present 
Secondary ducts --- Ectasia --- Visible 
Calcifications and cysts > 5mm --- Present  
Table 1. Echoendoscopic criteria for chronic pancreatitis.  
US establishes criteria only in severe CP. There are no criteria for mild and moderate CP 
(28). Figures 3, 4, 5 and 6 show different echoendoscopic degrees of CP. EE has described 
new imaging criteria to diagnose CP (29). 
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Fig. 3. Echoendoscopic images in patients with abdominal pain. (a) Hypoechoic areas, 
intermingled with normal parenchyma and hyperechoic streaks. The aspect remembers a 
"honeycomb". This aspect suggests early-stage chronic pancreatitis. (b) The same aspect, but 
more pronounced. 
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Fig. 4. Echoendoscopic image of a lobulated pancreatic gland, with hyperechoic striations 
interspersed with oval hypoechoic areas, and discrete posterior hyperechoic enhancement. 
This aspect suggests moderate CP. 
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Fig. 5. Echoendoscopic aspect of calcifying CP. Hyperechoic areas with acoustic shadow and 
lobular aspect of the gland. (a) dilation of MPD and secondary ducts. 
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Fig. 6. Echoendoscopic images showing MPD with a single stone. 
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6. Echoendoscopy to diagnose early stage chronic pancreatitis  
Diagnosis of early stage is a huge challenge. The inability to obtain biopsies makes this 
presumptive diagnosis difficult. The avaiable diagnostic imaging methods do not offer 
greater benefits. EE is a promising diagnostic modality and unlike ERCP does not have the 
same complication rate. Minimal changes in echotexture are difficult to interpret because 
there is no gold standard (Figure 7). 
 
Fig. 7. Echoendoscopic image of pancreas showing parenchymal changes such as: 
longitudinal hyperechoic streaks, hypoechoic areas, secondary duct dilation and 
hypoechogenicity of the entire gland. 
There is some evidence in the literature suggesting that these early changes may progress to 
a more advanced disease (30). It is generally accepted that in the absence of all criteria, CP is 
unlikely, whereas when there is 5 or more of these criteria CP is likely, even when ERCP and 
pancreatic function tests are normal. Significance of 1-4 criteria is still uncertain, particularly 
if other diagnostic methods such as ERCP and functional tests are normal (30). In these 
cases, there is strong evidence of CP, even if these changes detected by EE could not be 
confirmed by other diagnostic modalities. A question still remains : How can we improve 
and understand the abnormalities detected by EE when other tests are normal? The answer 
can only be obtained from studies with more rigorous methodology. 
Yusoff & Sahai (31) prospectively studied 1157 patients. The most important predictive 
factor for parenchymal abnormalities was alcohol intake, male, clinical suspicion of 
pancreatic disease and smoking. The authors conclude that many variables can change 
echoendoscopic aspects and severe abnormalities may be found in asymptomatic 
individuals. The diagnosis of CP by EE needs to be assessed by clinical, functional and 
histological tests. 
In our department we investigated the meaning of echoendoscopic criteria for MPD and 
parenchyma abnormalities in patients without suspicion of CP compared to chronic 
alcoholics (alcohol intake exceeding 80g/ day). Two hundred and twenty-eight patients 
underwent EE. One hundred and eighty-nine were prospectively studied, using criteria of 
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Catalano et al. (26) and Sahai et al. (27). Alcoholic patients (p <0.001) showed more 
abnormalities than nonalcoholic for both scores (parenchyma and MPD). Comparison of 
ROC curve between the two groups showed a better specificity and sensitivity when the two 
scores were combined (29). Our results demonstrate a correlation between these signals and 
the disease, but it is important to emphasize that, in our opinion, echo-guided fine needle 
aspiration can aid diagnosis and, beyond a shadow of doubts, will be the gold standard for 
diagnosis of CP, particularly in early phase. 
7. Comparison between EE and ERCP 
Three studies compared EE to ERCP in order to correlate ultrasonographic and 
wirsungography signs with severity of CP. In the first, 35 patients with CP were analyzed. 
Sixty per cent of patients had a history of alcohol intake. There was clear correlation 
between alcohol abuse and CP (p <0.05) as well with abnormalities of MPD by EE with 
ERCP (p <0.01). These authors conclude that EE should be the first line method for diagnosis 
of parenchymal and MPD abnormalities (32). 
In the second study, the sensitivity and specificity of EE were 85%. CP is likely because it 
has a positive predictive value of 85% when more than two criteria (for all CP) or more than 
six criteria (for moderate and severe forms) are present. Moderate or severe CP is unlikely 
when less than three criteria are present (negative predictive value> 85%). Independent 
predictive factors of CP were: calcifications (p = 0.000001), history of alcoholism (p = 0.002) 
and total number of criteria (p = 0.008) (27). 
In the third study, EE and ERCP were compared with a functional (secretin test) and 
showed a sensitivity and specificity of 84% and 98% to diagnose CP. Although correlation 
between EE and ERCP is excellent in normal pancreas or in moderate or advanced forms of 
CP, in early forms it is poor (26). Another study reported sensitivity and specificity of 87% 
and 89% to diagnose CP (33). 
Another study compared the agreement among 11 experienced echoendoscopists to 
diagnose CP. There was agreement for a definitive diagnosis of CP (Kappa index = 0.45). 
Agreement was higher for criteria such as ductal dilatation (kappa = 0.6) and lobular aspect 
(kappa = 0.51). All other parameters showed poor agreement (kappa <0.4). The authors 
conclude that EE is reliable to diagnose CP, with good correlation among experienced 
observers (34). 
8. Echoendoscopy (EE) alone and associated with fine needle aspiration 
(FNA-EE) 
Hollerbach et al. (8) has recently reported the value of EE with fine needle aspiration 
puncture (FNAB) to diagnose CP. They concluded that EE is so sensitive and effective as 
ERCP to detect CP, particularly in early cases. However, echoendoscopic aspects are poor, 
especially in patients with early disease. EE-FNA is safe and increases negative predictive 
value of EE. A negative puncture and the absence of echoendoscopic findings of CP could 
exclude it. It is noteworthy that cytology alone does not increase the specificity of the 
method, suggesting that tissue collection could impose the use of EE-FNA as a routine to 
diagnose CP at any stage.  
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We agree with it. 
Patients with CP show another diagnostic difficulty : differencial diagnosis between a real 
pancreatic mass and a pseudotumour. This diagnosis is relatively difficult to make and an 
accurate diagnosis could avoid unnecessary surgical treatment (35). Several techniques 
associated with EE have been described for this purpose. The use of Echo-guided Power 
Doppler for differential diagnosis showed sensitivity and specificity of 93% and 77% 
respectively (35). The use of contrast agent (Sonovue) seems to increase sensitivity and 
specificity rates to 91% compared to EE alone versus 73% and 93% vs. 83%, respectively (36). 
Echo-guided elastography also contributes for diagnosis, but studies are still preliminary 
and need further confirmation (35). 
EE-FNA has a sensitivity, specificity, positive and negative predictive value and accuracy of 
87.5%, 100%, 100%, 98.1% and 98.3% respectively, for differencial diagnosis between 
inflammatory mass and CP (37). 
9. Conclusion 
EE has continuously gained importance and has proven to be of clinical value in patients 
with CP, as it has a low complication rate when compared to ERCP. Some authors indicate 
EE for examining CP, as it is the imaging method of choice to asses MPD and parenchyma 
criteria, but there are some limitations. EE has two main limitations that prevent it being the 
gold standard: the lack of standard criteria for appropriate education and learning (38). 
EE is difficult to learn and therefore, teaching has to be standardized. Moreover, a general 
platform to compare Cambridge criteria is necessary, in order to be accepted as the gold 
standard to diagnose CP. Except calcifications, the difficulties in assessing some 
parenchymal criteria depend on differentiation of the natural aging process, the sequelae of 
pancreatic fibrosis, acute ingestion of alcohol and the advanced stage of CP. Another 
important point to mention is that the differentiation of hypoechoic (inflammatory x cancer) 
and cystic lesions (inflammatory x neoplastic) is difficult. In this area, complementary 
imaging methods have also low sensitivity. Thus there is no doubt that EE has proven to be 
useful to diagnose CP and its complications (38). 
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